202 related articles for article (PubMed ID: 32831069)
41. Low-dose benznidazole treatment results in parasite clearance and attenuates heart inflammatory reaction in an experimental model of infection with a highly virulent Trypanosoma cruzi strain.
Cevey ÁC; Mirkin GA; Penas FN; Goren NB
Int J Parasitol Drugs Drug Resist; 2016 Apr; 6(1):12-22. PubMed ID: 26862474
[TBL] [Abstract][Full Text] [Related]
42. Usefulness of the polymerase chain reaction for monitoring cure of mice infected with different Trypanosoma cruzi clonal genotypes following treatment with benznidazole.
Miyamoto CT; Gomes ML; Marangon AV; de Araújo SM; Bahia MT; Martins-Filho OA; de Lana M; de Ornelas Toledo MJ
Exp Parasitol; 2008 Sep; 120(1):45-9. PubMed ID: 18533149
[TBL] [Abstract][Full Text] [Related]
43. Reduced Trypanosoma cruzi-specific humoral response and enhanced T cell immunity after treatment interruption with benznidazole in chronic Chagas disease.
Castro Eiro MD; Natale MA; Alvarez MG; Shen H; Viotti R; Lococo B; Bua J; Nuñez M; Bertocchi GL; Albareda MC; Cesar G; Tarleton RL; Laucella SA
J Antimicrob Chemother; 2021 May; 76(6):1580-1592. PubMed ID: 33693664
[TBL] [Abstract][Full Text] [Related]
44. In vitro and in vivo drug combination for the treatment of Trypanosoma cruzi infection: A multivariate approach.
Strauss M; Rodrigues JHS; Lo Presti MS; Bazán PC; Báez AL; Paglini-Oliva P; Nakamura CV; Bustamante JM; Rivarola HW
Exp Parasitol; 2018 Jun; 189():19-27. PubMed ID: 29726395
[TBL] [Abstract][Full Text] [Related]
45. Benznidazole/Poloxamer 407 Solid Dispersion as a New Strategy to Improve the Treatment of Experimental Trypanosoma cruzi Infection.
Davies C; Simonazzi A; Micheloud JF; Ragone PG; Cid AG; Negrette OS; Bermúdez JM; Parada LA
J Parasitol; 2020 Jun; 106(3):323-333. PubMed ID: 32369594
[TBL] [Abstract][Full Text] [Related]
46. Molecular and biological characterization of a highly pathogenic Trypanosoma cruzi strain isolated from a patient with congenital infection.
Gulin JEN; Bisio M; Rocco DM; Altcheh J; Solana ME; García-Bournissen F
Exp Parasitol; 2018 Mar; 186():50-58. PubMed ID: 29448038
[TBL] [Abstract][Full Text] [Related]
47. Diagnosis of congenital Trypanosoma cruzi infection: A serologic test using Shed Acute Phase Antigen (SAPA) in mother-child binomial samples.
Volta BJ; Russomando G; Bustos PL; Scollo K; De Rissio AM; Sánchez Z; Cardoni RL; Bua J
Acta Trop; 2015 Jul; 147():31-7. PubMed ID: 25847262
[TBL] [Abstract][Full Text] [Related]
48. Clinical and pharmacological profile of benznidazole for treatment of Chagas disease.
Kratz JM; Garcia Bournissen F; Forsyth CJ; Sosa-Estani S
Expert Rev Clin Pharmacol; 2018 Oct; 11(10):943-957. PubMed ID: 30111183
[TBL] [Abstract][Full Text] [Related]
49. Pentamidine antagonizes the benznidazole's effect in vitro, and lacks of synergy in vivo: Implications about the polyamine transport as an anti-Trypanosoma cruzi target.
Seguel V; Castro L; Reigada C; Cortes L; Díaz MV; Miranda MR; Pereira CA; Lapier M; Campos-Estrada C; Morello A; Kemmerling U; Maya JD; López-Muñoz R
Exp Parasitol; 2016 Dec; 171():23-32. PubMed ID: 27729250
[TBL] [Abstract][Full Text] [Related]
50. Concomitant Benznidazole and Suramin Chemotherapy in Mice Infected with a Virulent Strain of Trypanosoma cruzi.
Santos EC; Novaes RD; Cupertino MC; Bastos DS; Klein RC; Silva EA; Fietto JL; Talvani A; Bahia MT; Oliveira LL
Antimicrob Agents Chemother; 2015 Oct; 59(10):5999-6006. PubMed ID: 26169419
[TBL] [Abstract][Full Text] [Related]
51. Longitudinal follow up of serological response in children treated for Chagas disease.
Moscatelli G; Moroni S; García Bournissen F; González N; Ballering G; Schijman A; Corral R; Bisio M; Freilij H; Altcheh J
PLoS Negl Trop Dis; 2019 Aug; 13(8):e0007668. PubMed ID: 31465522
[TBL] [Abstract][Full Text] [Related]
52. Quantitative PCR as a marker for preemptive therapy and its role in therapeutic control in Trypanosoma cruzi/HIV coinfection.
Freitas VLT; Novaes CTG; Sartori AMC; Carvalho NB; Silva SCVD; Nakanishi ÉS; Salvador F; Castro CN; Bezerra RC; Westphalen EVN; Oliveira CMR; Busser FD; Ho YL; Buccheri R; Bonilla C; Shikanai-Yasuda MA
PLoS Negl Trop Dis; 2024 Feb; 18(2):e0011961. PubMed ID: 38408095
[TBL] [Abstract][Full Text] [Related]
53. Congenital transmission of Trypanosoma cruzi: an operational outline for detecting and treating infected infants in north-western Argentina.
Blanco SB; Segura EL; Cura EN; Chuit R; Tulián L; Flores I; Garbarino G; Villalonga JF; Gürtler RE
Trop Med Int Health; 2000 Apr; 5(4):293-301. PubMed ID: 10810029
[TBL] [Abstract][Full Text] [Related]
54. Evaluation of Trypanosoma cruzi parasitic load by real-time PCR and blood culture in long-term kidney transplant recipients.
Jesus Guimarães Ferreira J; Antonio de Almeida E; Barbosa Marcon GE; Gonçalves Lima R; Barroso Pereira M; Ramos Gadelha F; Mazzali M; Martins LC; Silva Wanderley J; Botelho Costa SC
J Infect Dev Ctries; 2021 Nov; 15(11):1774-1781. PubMed ID: 34898511
[TBL] [Abstract][Full Text] [Related]
55. Antitrypanosomal Activity of Sterol 14α-Demethylase (CYP51) Inhibitors VNI and VFV in the Swiss Mouse Models of Chagas Disease Induced by the Trypanosoma cruzi Y Strain.
Guedes-da-Silva FH; Batista DG; Da Silva CF; De Araújo JS; Pavão BP; Simões-Silva MR; Batista MM; Demarque KC; Moreira OC; Britto C; Lepesheva GI; Soeiro MN
Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28167559
[TBL] [Abstract][Full Text] [Related]
56. Recent clinical trials for the etiological treatment of chronic chagas disease: advances, challenges and perspectives.
Urbina JA
J Eukaryot Microbiol; 2015; 62(1):149-56. PubMed ID: 25284065
[TBL] [Abstract][Full Text] [Related]
57. Molecular diagnosis and treatment monitoring of congenital transmission of Trypanosoma cruzi to twins of a triplet delivery.
Burgos JM; Altcheh J; Petrucelli N; Bisio M; Levin MJ; Freilij H; Schijman AG
Diagn Microbiol Infect Dis; 2009 Sep; 65(1):58-61. PubMed ID: 19679236
[TBL] [Abstract][Full Text] [Related]
58. New Scheme of Intermittent Benznidazole Administration in Patients Chronically Infected with Trypanosoma cruzi: a Pilot Short-Term Follow-Up Study with Adult Patients.
Álvarez MG; Hernández Y; Bertocchi G; Fernández M; Lococo B; Ramírez JC; Cura C; Albizu CL; Schijman A; Abril M; Sosa-Estani S; Viotti R
Antimicrob Agents Chemother; 2016 Feb; 60(2):833-7. PubMed ID: 26596935
[TBL] [Abstract][Full Text] [Related]
59. A Parasite Biomarker Set for Evaluating Benznidazole Treatment Efficacy in Patients with Chronic Asymptomatic Trypanosoma cruzi Infection.
Egui A; Thomas MC; Fernández-Villegas A; Pérez-Antón E; Gómez I; Carrilero B; Del Pozo Á; Ceballos M; Andrés-León E; López-Ruz MÁ; Gainza E; Oquiñena E; Segovia M; López MC
Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31358581
[TBL] [Abstract][Full Text] [Related]
60. Impact of benznidazole treatment on the functional response of Trypanosoma cruzi antigen-specific CD4+CD8+ T cells in chronic Chagas disease patients.
Pérez-Antón E; Egui A; Thomas MC; Puerta CJ; González JM; Cuéllar A; Segovia M; López MC
PLoS Negl Trop Dis; 2018 May; 12(5):e0006480. PubMed ID: 29750791
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
